StockData
Curaleaf Holdings, Inc. logo

Curaleaf Holdings, Inc. (CURLF) stock

CURLFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30
$7.63−0.20 (-2.55%)

Close on Oct 19, 2026Market cap $2.07BP/E –Yield –

Curaleaf Holdings, Inc. saw revenue fall 5.0% to $1.27B over fiscal 2025. Operating income rose 2.9% to $25.45M, moving the operating margin from 1.9% to 2.0%. Free cash flow was $74.27M, up 4.3% from a year earlier. At the latest close the market valued the company at $2.07B.

Revenue
$1.27B
-5.0% vs. a year earlier
Operating income
$25.45M
+2.9% vs. a year earlier
Free cash flow
$74.27M
+4.3% vs. a year earlier
EPS, diluted
-$1.05
FY2025

Key statistics

Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026

Valuation

Market cap
$2.07B
P/E ratio
–
Price to sales
1.63
Price to book
2.38
Dividend yield
–
Free cash flow yield
3.60%

Fundamentals

Revenue
$1.27B
Net income
-$231.07M
EPS, diluted
-$1.05
Free cash flow
$74.27M
Book value per share
$3.20
Diluted shares
271M

Trading

Previous close
$7.83
Open
$7.99
Day's range
$7.31 – $8.00
Volume
175,454
Average volume (20 days)
241,638

Market cap history

Month-end market cap since 2020, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodCURLFS&P 500DifferenceCURLF per yearS&P 500 per year
1 month-27.1%+0.6%−27.8 pts
3 months-18.4%+3.4%−21.8 pts
Year to date+0.9%+13.3%−12.4 pts
1 year-11.4%+16.6%−28.0 pts
3 years-31.3%+86.4%−117.6 pts-11.7%+23.1%
5 years-76.4%+81.9%−158.3 pts-25.1%+12.7%

Eight years at a glance

Fiscal years 2018 to 2025, USD

Revenue

$1.27B-5.0% YoY

Gross profit

$631.02M-1.5% YoY

Operating income

$25.45M+2.9% YoY

Net income

-$231.07M

EPS, diluted

-$1.05

Free cash flow

$74.27M+4.3% YoY
Reported period

Press releases

Releases Curaleaf filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Curaleaf

Medicinal Chemicals & Botanical Products

Curaleaf Holdings, Inc. operates in the cannabis industry, producing and distributing cannabis and hemp products. The company functions primarily through two operating segments: a domestic segment and an international segment. Its primary commercial operations involve the cultivation, processing, and distribution of cannabis raw materials and finished goods, which generate revenue through retail dispensaries, wholesale transactions, and management services. Curaleaf serves retail consumers through its dispensary network, including adult-use customers, as well as wholesale clients and commercial partners.

Company profile, executives and history

Curaleaf stock: common questions

What is Curaleaf's stock price?

CURLF closed at $7.63 on Oct 19, 2026, down 2.55% on the day.

What is Curaleaf's market cap?

Curaleaf was worth $2.07B at the close on Oct 19, 2026: the share price times the diluted shares outstanding.

What is CURLF's P/E ratio?

Curaleaf lost money over fiscal 2025 (diluted EPS -$1.05), so it has no meaningful P/E ratio.

How much revenue does Curaleaf make?

Curaleaf reported revenue of $1.27B for fiscal 2025, down 5.0% from a year earlier.

Does Curaleaf pay a dividend?

No. Curaleaf has not paid a cash dividend over the last twelve months.

How has CURLF stock performed over the past year?

Including dividends, CURLF returned -11.4% over the past year, against +16.6% for the S&P 500.

Who are Curaleaf's competitors?

Companies most similar to Curaleaf by business, industry and size include CRLBF, TRLV, TLRY, CGC, SNDL.

See a number that looks wrong?